Spanish periodical EL MUNDO reveals its top 25 of the most influential Spanish Citizens in Medicine for 2014

VHIO Communications talks to Josep Villanueva, PI of VHIO´s Tumour Biomarkers Group, about the latest developments in tumour biomarkers and…

Barcelona, September 15, 2015– We can only hope to collectively accelerate the pace in advancing more precisely targeted therapies against…

Approximately 30% of all breast cancers currently diagnosed have a genetic abnormality

The Vall d´Hebron Institute of Oncology (VHIO), invites immediate applications from outstanding individuals to establish and maintain energetic, independent and…

According to the first independent, benchmark evaluation of the Spanish healthcare sector, Monitor de Reputación Sanitaria (MRS), issued by the…

The Symposium´s educational supporter, the Fundació Bancària “la Caixa”, backs this first-class two-day exploration into the most relevant and recent…

IMPORTANT NOTIFICATION: As an update to this earlier news item (see below), Pau´s fundraising concert on the 22nd December is…

Announced last week, the third edition of the CaixaImpulse call – a funding program created by the Fundació Bancària la…

Principle Investigator of VHIO´s Mouse Models of Cancer Therapy Group, Laura Soucek has been awarded this year´s Fero (Fundación de Investigación Oncológica) grant for translational cancer research for her pioneering work using mouse models to counteract tumoral activity triggered by ´the oncogene from Hell´*, Myc.

Launched in December last year, the European Society of Medical Oncology´s (ESMO) digital magazine – accessible to members and non-members…

Source: ESMO Lugano, Switzerland, 23 June 2015 – The European Society for Medical Oncology (ESMO), the leading pan-European organisation in…

 • An international study, with the participation of over 500,000 women, reveals that women who are married when diagnosed with breast cancer have a better chance of survival, regardless of tumor characteristics

• The study, in which the Vall d´Hebron University Hospital and the Vall d’Hebron Institute of Oncology (VHIO) have participated, will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)

The Hinnovar awards, organized by Novartis in collaboration with ESADE and the Spanish Society of Health Directives (SEDISA), aim to…

• GSK undertakes global consortium incorporating six prestigious cancer research centers • The Oncology Clinical and Translational Consortium (OCTC) includes…